Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Bayer Schering Pharma: PharmaVitae Profile' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Bayer Schering Pharma AG: PharmaVitae Profile |
July 2009 | £5700 | 100 % |
|
Bayer Schering Pharma Ag PharmaVitae Profile |
July 2008 | £3010 | 48.5 % |
|
Bayer Schering Pharma AG - SWOT Analysis |
March 2008 | £66 | 36.5 % |
|
Schering AG - SWOT Analysis |
October 2008 | £66 | 35 % |
|
Mergers and Acquisitions in the Pharmaceuticals Sector, 2009 Critical success factors for competing in a consolidating market |
April 2009 | £1955 | 12.25 % |
|
Mergers and Aquisitions in the Pharmaceuticals Sector, 2009 Critical success factors for competing in a consolidating market |
April 2009 | £995 | 12.25 % |
|
Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape |
August 2008 | £3800 | 11.9 % |
|
Rimonabant: The first of the Cannabinoid blockbusters |
June 2007 | £1499 | 11 % |
|
Innovative And Targeted Cancer Therapies Key Technologies, New Applications And Leading Players |
July 2007 | £1495 | 9.1 % |
|
Bigpharma Dealmaking Handbook Companies & Contacts |
September 2008 | £1195 | 8.75 % |
|
Bigpharma Dealmaking and Agreements Handbook 2007 Companies, Contacts & Partnering Agreements |
September 2007 | £1195 | 8.4 % |
|
Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis |
August 2009 | £2140 | 8.4 % |
|
China Pharma Outsourcing Annual Review 2009 |
November 2009 | £880 | 6.3 % |
|
Partnering with Biopharma The definitive guide to bigpharma partnering interests, contacts & agreements |
July 2008 | £1495 | 6.3 % |
|
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends |
November 2007 | £7600 | 6.3 % |
|
Advanced Digital Diagnostic Medical Imaging Equipment Market Analysis & Directions |
September 2009 | £1605 | 5.6 % |
|
The Dermatology Market Outlook to 2013 Competitive Landscape, Pipeline Analysis and Growth Opportunities |
October 2008 | £2025 | 5.6 % |
|
Leukemia A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking |
April 2009 | £1700 | 5.25 % |
|
Monoclonal Antibodies in Cancer Therapy 2009-2024 |
May 2009 | £1499 | 4.9 % |
|
United States Drug Delivery Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies |
April 2008 | £1910 | 4.55 % |
|
Competitive Outlook of Cancer Drug Development The Missing Handbook to New Product Planning and Portfolio Planning |
August 2009 | £2140 | 4.2 % |
|
Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 |
May 2008 | £1910 | 4.2 % |
|
China Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 |
May 2008 | £1910 | 3.85 % |
|
Forecast Insight: Multiple Sclerosis Tysabri to prevail despite safety setbacks |
August 2008 | £7600 | 3.85 % |
|
United States Drug Delivery Devices Investment Opportunities Analysis and Forecasts to 2012 |
September 2008 | £1910 | 3.5 % |
|
Pipeline/Commercial Insight: Supportive Care in Oncology Significant growth opportunities exist in new supportive care indications |
June 2007 | £7600 | 3.5 % |
|
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies More drugs on the market, more targets in the pipeline |
October 2006 | £8000 | 3.15 % |
|
ASCO 2009: Significant Developments in Context |
July 2009 | £595 | 2.8 % |
|
The Executive Guide to Molecular Imaging |
July 2007 | £595 | 2.8 % |
|
Epigenomics Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics |
March 2007 | £3085 | 2.45 % |
|
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012 |
April 2007 | £1499 | 2.45 % |
|
Monoclonal Antibody Therapeutics 2009-2024 |
August 2009 | £1499 | 1.75 % |
|
PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2009 / 2010 |
June 2009 | £270 | 1.75 % |
|
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008 |
May 2007 | £270 | 1.75 % |
